miklos pless
机构: Kantonsspital Winterthur
每年引用次数
引用次数
引用: 15,662
H-指数: 48
I10-指数 : 106
出版物: 371
Effect of a leucine-rich supplement in combination with nutrition and physical exercise in advanced cancer patients: A randomized controlled intervention trial.
Lena J. Storck , Maya Ruehlin , Sabine Gaeumann , David Gisi
Clinical Nutrition 39 ( 12) 3637 -3644
7
2020
Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer.
Markus Solèr , Andreas Lohri , Christoph Rochlitz , Richard Herrmann
Radiotherapy and Oncology 56 ( 2) 169 -173
8
2000
Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients A prospective, randomized, single-center study
Thomas Egger , Alois Gratwohl , Andr� Tichelli , Mario Uhr
Supportive Care in Cancer 3 ( 2) 139 -146
35
1995
Glioblastoma in the era of bevacizumab: An epidemiological study in the Canton of Zurich, Switzerland, 2010-2014.
Dorothee Gramatzki , Patrick Roth , Elisabeth Jane Rushing , Jonathan Weller
Journal of Clinical Oncology 36 ( 15_suppl) e14062 -e14062
2018
Multimodal treatment in operable stage III non-small cell lung cancer using the new TNM staging classification version 8: Long term results of a pooled analysis of three SAKK trials.
Martin Frueh , Daniel C. Betticher , Roger Stupp , Alexandros Xyrafas
Journal of Clinical Oncology 36 ( 15_suppl) 8531 -8531
2018
Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
Prashant N. Chhajed , Florent Baty , Miklos Pless , Stephanie Somandin
Chest 130 ( 6) 1803 -1807
74
2006
Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: a randomized controlled trial.
Alexandra Uster , Ursula Ruefenacht , Maya Ruehlin , Miklos Pless
Nutrition 29 ( 11) 1342 -1349
60
2013
Neoadjuvant chemotherapy with or without preoperative irradiation in stage IIIA/N2 non-small cell lung cancer (NSCLC): A randomized phase III trial by the Swiss Group for Clinical Cancer Research (SAKK trial 16/00).
Miklos Pless , Roger Stupp , Hans-Beat Ris , Rolf A. Stahel
Journal of Clinical Oncology 31 7503 -7503
15
2013
EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
Florent Baty , Sacha Rothschild , Martin Früh , Daniel Betticher
PLOS ONE 8 ( 9)
10
2013
EPID-16PATTERNS OF CARE AND OUTCOME IN GLIOBLASTOMA PATIENTS IN THE CANTON OF ZURICH: A POPULATION-BASED STUDY (2005-2009)
Dorothee Gramatzki , Silvia Dehler , Elisabeth Rushing , Kathrin Zaugg
Neuro-Oncology 17 ( suppl 5) v81.3 -v81
2015
Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.
Ralph Winterhalder , Simone Deschler-Marini , Christine Landmann , Roger Kann
Radiotherapy and Oncology 73 ( 3) 321 -324
7
2004
3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis.
Seth Helfenstein , Oliver Riesterer , Urs R. Meier , Alexandros Papachristofilou
Radiation Oncology 14 ( 1) 1 -10
10
2019
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
Jose R. Pereira , Filippo De Marinis , Joachim von Pawel , Ulrich Gatzemeier
Journal of Clinical Oncology 22 ( 9) 1589 -1597
2,100
2004
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer
Christoph Rochlitz , Robert Figlin , Patrick Squiban , Marc Salzberg
Journal of Gene Medicine 5 ( 8) 690 -699
203
2003
EGFR Exon-Level Biomarkers Of The Response To Bevacizumab-Erlotinib (BE) In Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - A Translational Substudy Of SAKK 19/05
Florent Baty , Sacha Rotschild , Martin Fruh , Susanne Crowe
american thoracic society international conference
2012
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC.
David König , Urs R. Meier , Bernd Klaeser , Spasenija Savic
Case Reports in Oncology 13 ( 2) 729 -732
2020
Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)
Richard Cathomas , Christian Rothermundt , Dirk Klingbiel , Lukas Bubendorf
Clinical Cancer Research 18 ( 21) 6049 -6057
27
2012
A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered bodily interventions (KPTK): study protocol
Astrid Grossert , Cornelia Meffert , Viviane Hess , Christoph Rochlitz
BMC Psychology 7 ( 1) 1 -13
1
2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou , Madeleine M. Hipp , Ute Klinkhardt , Martin Früh
Journal for ImmunoTherapy of Cancer 7 ( 1) 38
26
2019
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
Roger Stupp , Michael Mayer , Roger Kann , Walter Weder
Lancet Oncology 10 ( 8) 785 -793
78
2009